Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xtant Medical Holdings (XTNT) Total Current Liabilities (2016 - 2025)

Historic Total Current Liabilities for Xtant Medical Holdings (XTNT) over the last 17 years, with Q3 2025 value amounting to $35.5 million.

  • Xtant Medical Holdings' Total Current Liabilities rose 544.71% to $35.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $35.5 million, marking a year-over-year increase of 544.71%. This contributed to the annual value of $28.6 million for FY2024, which is 2431.93% up from last year.
  • Latest data reveals that Xtant Medical Holdings reported Total Current Liabilities of $35.5 million as of Q3 2025, which was up 544.71% from $30.6 million recorded in Q2 2025.
  • Over the past 5 years, Xtant Medical Holdings' Total Current Liabilities peaked at $35.5 million during Q3 2025, and registered a low of $10.4 million during Q3 2021.
  • Moreover, its 5-year median value for Total Current Liabilities was $21.9 million (2023), whereas its average is $21.2 million.
  • Examining YoY changes over the last 5 years, Xtant Medical Holdings' Total Current Liabilities showed a top increase of 13869.17% in 2021 and a maximum decrease of 5681.31% in 2021.
  • Xtant Medical Holdings' Total Current Liabilities (Quarter) stood at $11.1 million in 2021, then skyrocketed by 37.38% to $15.2 million in 2022, then surged by 51.07% to $23.0 million in 2023, then grew by 24.32% to $28.6 million in 2024, then increased by 24.22% to $35.5 million in 2025.
  • Its last three reported values are $35.5 million in Q3 2025, $30.6 million for Q2 2025, and $29.6 million during Q1 2025.